ArticleThe pharmacogenomics journal2019

Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.

Maria Plesa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.